...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations
【24h】

Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations

机译:作为天然抗炎剂的氮烯加载的固体脂质纳米粒子的制备,表征和优化:体内和体外评估

获取原文
获取原文并翻译 | 示例

摘要

Auraptene (AUR) is a bioactive antioxidant coumarin with valuable pharmacological properties; however, poor water solubility is a substantial issue for the topical application of AUR. Therefore, we sought to prepare solid lipid nanoparticles (SLNs) containing AUR (AUR-SLNs) to enhance its anti-inflammatory effect. The prepared formulations were optimized by applying the response surface method. Furthermore, AUR-SLNs were compared to conventional cream containing AUR regarding both the permeation rate of the nanoparticles and the anti-inflammatory effect through both in vitro and in vivo studies. Particle size and entrapment efficiency of the optimized formulation were 140.9 +/- 3.55 nm and 84.11% +/- 3.30, respectively. Transmission electron microscopy revealed that the nanoparticles were spherical. Differential scanning calorimetry (DSC) analysis demonstrated no drug-lipid incompatibility in the formulation. Fourier transform-infrared spectroscopy (FTIR) spectra revealed the amorphous state of AUR and the encapsulation of this agent in SLNs. The in vitro permeation studies exhibited that AUR-SLNs could significantly enhance cutaneous uptake of AUR and skin targeting. The anti-inflammatory and histopathological studies exhibited no significant differences between AUR-SLNs and indomethacin. AUR-SLNs did not induce skin sensitization in guinea pigs. The results suggest that SLNs could be appropriate carriers for the topical application of AUR as a natural anti-inflammatory agent. (C) 2018 Elsevier B.V. All rights reserved.
机译:AURAPTENE(AUR)是一种具有宝贵药理学特性的生物活性抗氧化库仑;然而,差的水溶解度是Aur局部应用的重要问题。因此,我们试图制备含有Aur(Aur-SLN)的固体脂质纳米颗粒(SLN),以增强其抗炎作用。通过施加响应面方法优化制备的制剂。此外,将Aur-S1N与常规乳膏进行比较,含有纳米颗粒的渗透率和通过体外和体内研究的抗炎作用的渗透率和抗炎作用。优化制剂的粒度和夹带效率分别为140.9 +/- 3.55nm和84.11%+/- 3.30。透射电子显微镜显示纳米颗粒是球形的。差分扫描量热法(DSC)分析证明了制剂中的药物 - 脂质不相容性。傅里叶变换 - 红外光谱(FTIR)光谱揭示了AUR的无定形状态和该试剂在SLN中的封装。体外渗透性研究表明,Aur-Slns可以显着增强Aur和皮肤靶向的皮肤吸收。抗炎和组织病理学研究表现出Aur-Slns和吲哚美辛之间没有显着差异。 Aur-Slns没有诱导豚鼠的皮肤致敏。结果表明,SLNS可以是用于局部施用AUR作为天然抗炎剂的适当载体。 (c)2018 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号